$GNPX
Genprex Inc

2022 Q4 Form 10-Q Financial Statement

#000143774922027048 Filed on November 14, 2022

View on sec.gov

Income Statement

Concept 2022 Q4 2022 Q3 2021 Q3
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $3.497M $2.511M $2.000M
YoY Change 59.25% 25.53% 40.88%
% of Gross Profit
Research & Development $3.319M $3.593M $1.432M
YoY Change -4.64% 150.93% 6.07%
% of Gross Profit
Depreciation & Amortization $6.080K $6.224K $6.489K
YoY Change -12.52% -4.08% 13.56%
% of Gross Profit
Operating Expenses $6.822M $3.593M $1.432M
YoY Change 20.04% 150.93% 6.07%
Operating Profit -$6.111M -$3.439M
YoY Change 77.69% 23.81%
Interest Expense $55.60K $27.88K $1.060K
YoY Change 5516.16% 2530.19%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$6.766M -$6.083M -$3.438M
YoY Change 19.08% 76.93% 24.11%
Income Tax
% Of Pretax Income
Net Earnings -$6.766M -$6.083M -$3.438M
YoY Change 19.08% 76.93% 23.89%
Net Earnings / Revenue
Basic Earnings Per Share -$0.13 -$0.07
Diluted Earnings Per Share -$0.14 -$126.8K -$72.21K
COMMON SHARES
Basic Shares Outstanding 48.03M 48.02M 47.53M
Diluted Shares Outstanding

Balance Sheet

Concept 2022 Q4 2022 Q3 2021 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $20.95M $25.52M $42.02M
YoY Change -45.76% -39.28% 99.53%
Cash & Equivalents $20.95M $25.52M $42.02M
Short-Term Investments
Other Short-Term Assets $484.2K $757.3K $749.0K
YoY Change -5.31% 1.1% -22.78%
Inventory $2.875M
Prepaid Expenses
Receivables $34.85K $34.85K $127.00
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $21.47M $26.31M $45.64M
YoY Change -45.14% -42.36% 100.98%
LONG-TERM ASSETS
Property, Plant & Equipment $23.03K $29.11K $44.34K
YoY Change -52.62% -34.35% 4.73%
Goodwill
YoY Change
Intangibles $702.1K $682.1K $627.4K
YoY Change 9.3% 8.72% 6.75%
Long-Term Investments
YoY Change
Other Assets $3.589M $3.609M $638.1K
YoY Change -2.3% 465.51% 6.63%
Total Long-Term Assets $3.612M $3.638M $682.4K
YoY Change -2.96% 433.03% 6.5%
TOTAL ASSETS
Total Short-Term Assets $21.47M $26.31M $45.64M
Total Long-Term Assets $3.612M $3.638M $682.4K
Total Assets $25.09M $29.95M $46.33M
YoY Change -41.48% -35.36% 98.39%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $442.9K $683.9K $591.9K
YoY Change -54.49% 15.53% 84.98%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $2.810M $2.457M $1.162M
YoY Change 77.27% 111.49% 209.3%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $2.810M $2.457M $1.162M
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $2.810M $2.457M $1.162M
YoY Change 77.27% 111.49% 205.76%
SHAREHOLDERS EQUITY
Retained Earnings -$102.8M -$94.99M -$72.34M
YoY Change 31.8% 31.32% 35.99%
Common Stock $48.11K $48.02K $47.80K
YoY Change 0.48% 0.45% 21.13%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $22.27M $27.49M $45.17M
YoY Change
Total Liabilities & Shareholders Equity $25.09M $29.95M $46.33M
YoY Change -41.48% -35.36% 98.39%

Cashflow Statement

Concept 2022 Q4 2022 Q3 2021 Q3
OPERATING ACTIVITIES
Net Income -$6.766M -$6.083M -$3.438M
YoY Change 19.08% 76.93% 23.89%
Depreciation, Depletion And Amortization $6.080K $6.224K $6.489K
YoY Change -12.52% -4.08% 13.56%
Cash From Operating Activities -$4.586M -$4.571M -$2.635M
YoY Change 42.52% 73.49% 31.08%
INVESTING ACTIVITIES
Capital Expenditures $20.00K -$16.05K -$19.03K
YoY Change -176.28% -15.66% -61.94%
Acquisitions
YoY Change
Other Investing Activities $39.68K $48.30K $187.3K
YoY Change -126.93% -74.22% -10.8%
Cash From Investing Activities $19.68K $32.25K $168.3K
YoY Change -111.34% -80.84% 12.19%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 4.680K 1.750K 243.5K
YoY Change -99.28% -69.17%
NET CHANGE
Cash From Operating Activities -4.586M -4.571M -2.635M
Cash From Investing Activities 19.68K 32.25K 168.3K
Cash From Financing Activities 4.680K 1.750K 243.5K
Net Change In Cash -4.562M -4.537M -2.223M
YoY Change 34.51% 104.1% 107.75%
FREE CASH FLOW
Cash From Operating Activities -$4.586M -$4.571M -$2.635M
Capital Expenditures $20.00K -$16.05K -$19.03K
Free Cash Flow -$4.606M -$4.555M -$2.616M
YoY Change 44.32% 74.14% 33.46%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2022Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period
SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
P10Y
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P10Y
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
48020324
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
48020324
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
47874708
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
47874708
CY2022Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-38244
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
90-0772347
dei Entity Address Address Line1
EntityAddressAddressLine1
3300 Bee Cave Road, #650-227
dei Entity Address City Or Town
EntityAddressCityOrTown
Austin
dei Entity Address State Or Province
EntityAddressStateOrProvince
TX
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
78746
dei City Area Code
CityAreaCode
512
dei Local Phone Number
LocalPhoneNumber
537-7997
dei Security12b Title
Security12bTitle
Common Stock, par value $0.001 per share
dei Trading Symbol
TradingSymbol
GNPX
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
true
dei Entity Shell Company
EntityShellCompany
false
CY2022Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
48025324
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
25516054 usd
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
38628876 usd
CY2022Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
34852 usd
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
0 usd
CY2022Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
757279 usd
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
511348 usd
CY2022Q3 us-gaap Assets Current
AssetsCurrent
26308185 usd
CY2021Q4 us-gaap Assets Current
AssetsCurrent
39140224 usd
CY2022Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
29109 usd
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
48608 usd
CY2022Q3 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
21818 usd
CY2021Q4 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
8691 usd
CY2022Q3 gnpx Research And Development Assets Noncurrent
ResearchAndDevelopmentAssetsNoncurrent
2904617 usd
CY2021Q4 gnpx Research And Development Assets Noncurrent
ResearchAndDevelopmentAssetsNoncurrent
3022403 usd
CY2022Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
682097 usd
CY2021Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
642360 usd
CY2022Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
3608532 usd
CY2022Q3 us-gaap Liabilities Current
LiabilitiesCurrent
2457311 usd
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
3673454 usd
CY2022Q3 us-gaap Assets
Assets
29945826 usd
CY2021Q4 us-gaap Assets
Assets
42862286 usd
CY2022Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
683871 usd
CY2021Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
973195 usd
CY2022Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
1773440 usd
CY2021Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
612100 usd
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1585295 usd
CY2022Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2022Q3 us-gaap Common Stock Value
CommonStockValue
48020 usd
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
47874 usd
CY2022Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
122432935 usd
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
119246970 usd
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-94992440 usd
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-78017853 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
27488515 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
41276991 usd
CY2022Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
29945826 usd
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
42862286 usd
CY2022Q3 us-gaap Revenues
Revenues
0 usd
CY2021Q3 us-gaap Revenues
Revenues
0 usd
us-gaap Revenues
Revenues
0 usd
us-gaap Revenues
Revenues
0 usd
CY2022Q3 us-gaap Depreciation
Depreciation
6224 usd
CY2021Q3 us-gaap Depreciation
Depreciation
6489 usd
us-gaap Depreciation
Depreciation
19498 usd
us-gaap Depreciation
Depreciation
15579 usd
CY2022Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3593309 usd
CY2021Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1431999 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
8191172 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
5127419 usd
CY2022Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2511121 usd
CY2021Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2000437 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
8798417 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
8774844 usd
CY2022Q3 us-gaap Costs And Expenses
CostsAndExpenses
6110654 usd
CY2021Q3 us-gaap Costs And Expenses
CostsAndExpenses
3438925 usd
us-gaap Costs And Expenses
CostsAndExpenses
17009087 usd
us-gaap Costs And Expenses
CostsAndExpenses
13917842 usd
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-6110654 usd
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-3438925 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-17009087 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-13917842 usd
CY2022Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
27877 usd
CY2021Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
1060 usd
us-gaap Investment Income Interest
InvestmentIncomeInterest
34500 usd
us-gaap Investment Income Interest
InvestmentIncomeInterest
4146 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-6082777 usd
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-3437865 usd
us-gaap Net Income Loss
NetIncomeLoss
-16974587 usd
us-gaap Net Income Loss
NetIncomeLoss
-13913696 usd
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.13
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.07
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.35
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.30
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
47984724
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
47612419
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
47919626
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
46851241
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
30916490 usd
CY2021Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
25324330 usd
CY2021Q1 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
20650 usd
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
651088 usd
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-6489714 usd
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
50422845 usd
CY2021Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
110033 usd
CY2021Q2 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
21100 usd
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1116359 usd
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-3986118 usd
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
47684219 usd
CY2021Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
243548 usd
CY2021Q3 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
16800 usd
CY2021Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
658577 usd
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-3437865 usd
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
45165279 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
41276991 usd
CY2022Q1 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
17500 usd
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1452607 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-5722484 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
37024614 usd
CY2022Q2 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
17972 usd
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
538026 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-5169326 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
32411285 usd
CY2022Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
1754 usd
CY2022Q3 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
6900 usd
CY2022Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1151353 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-6082777 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
27488515 usd
us-gaap Net Income Loss
NetIncomeLoss
-16974587 usd
us-gaap Net Income Loss
NetIncomeLoss
-13913696 usd
us-gaap Depreciation
Depreciation
19498 usd
us-gaap Depreciation
Depreciation
15579 usd
us-gaap Share Based Compensation
ShareBasedCompensation
3184357 usd
us-gaap Share Based Compensation
ShareBasedCompensation
2484574 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
34852 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-0 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
259057 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
364476 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-289324 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
398973 usd
us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
1161340 usd
us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
312196 usd
gnpx Class Of Warrant Or Right Issued During Period Exercise Price
ClassOfWarrantOrRightIssuedDuringPeriodExercisePrice
1.44
gnpx Class Of Warrant Or Right Cancelled During Period
ClassOfWarrantOrRightCancelledDuringPeriod
112993
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-13192625 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-11066850 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
-0 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
20480 usd
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
39737 usd
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
25735 usd
gnpx Payments For Proceeds From Research And Development Supplies
PaymentsForProceedsFromResearchAndDevelopmentSupplies
-117786 usd
gnpx Payments For Proceeds From Research And Development Supplies
PaymentsForProceedsFromResearchAndDevelopmentSupplies
-135996 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
78049 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
89781 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
1754 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
25677911 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1754 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
25677911 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-13112822 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
14700842 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
38628876 usd
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
27319685 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
25516054 usd
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
42020527 usd
CY2018Q1 gnpx Capital Stock Shares Authorized
CapitalStockSharesAuthorized
210000000
CY2018Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2018Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2018Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2018Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><span style="text-decoration: underline; "><i>Use of Estimates</i></span></p> <p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"> </p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">The preparation of our unaudited condensed financial statements in conformity with GAAP requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited condensed financial statements and the reported amounts of expenses during the reporting period. Actual results could differ from those estimates.</p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"> </p>
CY2022Q3 us-gaap Cash Uninsured Amount
CashUninsuredAmount
25197934 usd
CY2021Q4 us-gaap Cash Uninsured Amount
CashUninsuredAmount
38392886 usd
CY2022Q3 gnpx Research And Development Assets Current
ResearchAndDevelopmentAssetsCurrent
2904617 usd
CY2021Q4 gnpx Research And Development Assets Current
ResearchAndDevelopmentAssetsCurrent
3022403 usd
us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
15000
gnpx Stock Issued During Period Shares Exercise Of Cashless Warrants
StockIssuedDuringPeriodSharesExerciseOfCashlessWarrants
13643
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
116973
CY2021 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
670889
CY2021 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
677912 usd
CY2021 us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
86138
CY2021 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
156045 usd
CY2018Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2018Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2018Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2018Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
48020324
CY2020Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
2154747
CY2020Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
4.37
CY2021 gnpx Class Of Warrant Or Right Issued In Period
ClassOfWarrantOrRightIssuedInPeriod
50000
CY2021 gnpx Class Of Warrant Or Right Issued During Period Exercise Price
ClassOfWarrantOrRightIssuedDuringPeriodExercisePrice
5.29
CY2021Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
2204747
CY2021Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
4.39
gnpx Class Of Warrant Or Right Issued In Period
ClassOfWarrantOrRightIssuedInPeriod
100000
gnpx Class Of Warrant Or Right Cancelled During Period Exercise Price
ClassOfWarrantOrRightCancelledDuringPeriodExercisePrice
4.47
gnpx Class Of Warrant Or Right Exercised During Period
ClassOfWarrantOrRightExercisedDuringPeriod
13643
gnpx Class Of Warrant Or Right Exercised During Period Exercise Price
ClassOfWarrantOrRightExercisedDuringPeriodExercisePrice
0.50
CY2022Q3 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
2178111
CY2022Q3 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
4.28
CY2022Q3 gnpx Class Of Warrant Or Right Vested Or Expected To Vest
ClassOfWarrantOrRightVestedOrExpectedToVest
25002
CY2022Q3 gnpx Class Of Warrant Or Right Vested Or Expected To Vest Weighted Average Exercise Price
ClassOfWarrantOrRightVestedOrExpectedToVestWeightedAverageExercisePrice
3.02
CY2022Q3 gnpx Class Of Warrant Or Right Exercisable
ClassOfWarrantOrRightExercisable
1869778
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y2M26D
CY2022Q3 gnpx Class Of Warrant Or Right Exercisable Exercise Price
ClassOfWarrantOrRightExercisableExercisePrice
4.63
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
11291827
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
2901166
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
66667
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
116973
CY2022Q3 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
0.02
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
2519628
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
118507
CY2021 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
670889
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y3M21D
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
6844069
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
2.81
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
2519628
CY2021 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
4.26
CY2021 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
670889
CY2021 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
1.01
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
118507
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
3.00
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
8574301
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
3.35
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
2901166
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
2.18
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
116973
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0.02
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
66667
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
2.55
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
11291827
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
3.09
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
578807
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
2.94
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
6579287
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
3.23
us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
51382 usd
CY2022Q1 us-gaap Other Commitment
OtherCommitment
340000 usd

Files In Submission

Name View Source Status
0001437749-22-027048-index-headers.html Edgar Link pending
0001437749-22-027048-index.html Edgar Link pending
0001437749-22-027048.txt Edgar Link pending
0001437749-22-027048-xbrl.zip Edgar Link pending
ex_423221.htm Edgar Link pending
ex_423222.htm Edgar Link pending
ex_423223.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
gnpx-20220930.xsd Edgar Link pending
gnpx20220930_10q.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R3.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
gnpx-20220930_cal.xml Edgar Link unprocessable
gnpx-20220930_lab.xml Edgar Link unprocessable
gnpx-20220930_def.xml Edgar Link unprocessable
gnpx-20220930_pre.xml Edgar Link unprocessable
gnpx20220930_10q_htm.xml Edgar Link completed
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending